Commercial name: Aortic Valve Prosthesis Pre-assembled Transcatheter in the Introducer System - LotusTM Valve - ANVISA registration number: 10341350785 - Risk class: IV - Maximum risk - Model affected: All. Serial number affected: All 의 안전성 경고

Agência Nacional de Vigilância Sanitária (ANVISA)에 따르면, 해당 안전성 경고 는 Brazil 에서 Boston Scientific do Brasil; Boston Scientific Limited. 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

안전성 경고는 의료기기 제품과 관련된 중요한 정보와 권고사항을 담고 있습니다. 물론 안전성 경고가 배포되었다고 해서 해당 제품이 무조건 안전하지 않은 제품이라는 것은 아닙니다. 보건의료업계 종사자와 의료기기 사용자들에게 배포되는 안전성 경고에는 회수(recall)도 포함될 수 있습니다. 제조사가 안전성 경고를 작성하기도 하지만, 보건당국에서 작성하는 경우도 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert
  • 사례 ID
    1913
  • 날짜
    2016-04-20
  • 사례 국가
  • 사례 출처
    ANVISA
  • 사례 출처 URL
  • 비고 / 경고
    Brazilian data is current through June 2018. All of the data comes from Anvisa, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Brazil.
  • 데이터 추가 비고
    Boston Scientific of Brazil informs that for the unit to be designated as independent, it should have completed the following: 1. Two doctors must be certified. To do so, they must have: a. Participated in face-to-face training; B. Performed at least 6 Lotus Valve procedures with a Prospective and Clinical Field Expert (FSC) from Boston Scientific; or performed at least 4 additional Lotus Valve procedures with a Boston Scientific Field Clinical Specialist (FSC). 2. Two members of the cath lab should be certified to prepare the Lotus Valve; 3. Certified physicians must be trained in Advanced Techniques by Boston Scientific of Brazil. If the unit is not independent, procedures should not be performed with the Lotus Valve without the support of a Boston Scientific Field Clinical Specialist (FSC).
  • 원인
    The company has identified the occurrence of procedures with the lotus valve without the mandatory support of a clinical field specialist (fsc) until the hospital is designated as "independent" by boston scientific.
  • 조치
    Security Alert. Code 2016-011 (Letter to Clients in Attachment)

Manufacturer

  • 제조사 모회사 (2017)
  • 제조사 의견
    “We take a patient-first approach to assessing the applicability of every recall and communicate to regulatory bodies in all geographies where the recalled device is sold,” Boston Scientific said in a statement to ICIJ. “We have coordinated several recalls across many countries in a timely manner,” the company said, adding that it complies with all national laws, which can often vary and require different processes for reporting information or taking action on recalls. The company said it uses a rigorous and uniform process to take action on recalls and that “when we initiate a field action (e.g. recall, safety alert), every customer who has received an affected product receives a communication that includes a letter for the physician.”
  • Source
    ANVSANVISA